Improved tumour response prediction with equivalent uniform dose in pre-clinical study using direct intratumoural infusion of liposome-encapsulated186Re radionuclides-Reference-Cited by-同舟云学术

Improved tumour response prediction with equivalent uniform dose in pre-clinical study using direct intratumoural infusion of liposome-encapsulated186Re radionuclides

Published:2011-08-12 Issue:17 Volume:56 Page:5721-5734
ISSN:0031-9155
Container-title:Physics in Medicine and Biology
language:
Short-container-title:Phys. Med. Biol.

Author:

Hrycushko Brian A,Ware Steve,Li Shihong,Bao Ande

Publisher

IOP Publishing

Subject

Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Reference32 articles.

1. Methodology to Incorporate Biologically Effective Dose and Equivalent Uniform Dose in Patient-Specific 3-Dimensional Dosimetry for Non-Hodgkin Lymphoma Patients Targeted with 131I-Tositumomab Therapy

2. Theoretical study of the influence of a heterogeneous activity distribution on intratumoral absorbed dose distribution

3. Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats

4. Radioimmunoimaging and radioimmunotherapy: Will these be routine procedures?

5. A detailed radiobiological and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape;EJNMMI Radiopharmacy and Chemistry;2024-05-04

2. Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives;Frontiers in Medicine;2019-06-14

3. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine;Advanced Drug Delivery Reviews;2019-03

4. Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in a Triple-Negative Breast Cancer Patient;Cancer Biotherapy and Radiopharmaceuticals;2019-02

5. Resistance and Heterogeneity of Intratumoral Antibody Distribution;Resistance to Targeted Anti-Cancer Therapeutics;2018